Key Validated Studies in Peer-reviewed Journals

1. Molina, C.R. et al. (2023) ‘Risk factor interactions, non–high‐density lipoprotein cholesterol to apolipoprotein B ratio, and severity of coronary arteriosclerosis in South Asian individuals: An observational cohort study’, Journal of the American Heart Association, 12(10). 

2. Puri, R. et al., (2020). ‘Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2020: Part III', Journal of The Association of Physicians of India. Nov;68(11[Special]):8-9. PMID: 33350610.

3. Behbodikhah, J. et al. (2021) ‘Apolipoprotein B and cardiovascular disease: Biomarker and potential therapeutic target’, Metabolites, 11(10), p. 690.

4. Zhang, X. et al. (2017) ‘Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: A meta-analysis’, Bioscience Reports, 37(5). 

5. Ormazabal, V. et al. (2018) ‘Association between insulin resistance and the development of cardiovascular disease’, Cardiovascular Diabetology, 17(1). 

6. Ridker, P.M. (2009) ‘The Jupiter Trial’, Circulation: Cardiovascular Quality and Outcomes', 2(3), pp. 279–285. 

7. Ganguly, P. and Alam, S.F. (2015) ‘Role of homocysteine in the development of cardiovascular disease’, Nutrition Journal, 14(1).